/Research Database
← Research Database
Sehr niedrig2026

Identification and validation of STEAP3 as a ferroptosis-related biomarker in heart failure.

Huijuan Chen, Lingqi Xu

Kernaussage

We identified aging-related programmed cell death signatures in heart failure and developed a tissue-based molecular diagnostic model with potential biomarker value, where STEAP3 was found to be downregulated and may contribute to ferroptosis-related injury in cardiomyocytes.

Abstract

Heart failure (HF) is a major health threat, with aging and programmed cell death (PCD) playing key roles. However, the link between aging-related PCD (aging-PCD) genes and HF remains unclear. We used ssGSEA and random forest to analyze PCD types in HF, identified aging-related PCDs via correlation analysis, and applied eight machine learning algorithms to develop a diagnostic model. SHAP and LIME were used to explain key features, and the relationship between the aging-PCD index and immune microenvironment was explored. Gene expression was verified by qRT-PCR, and the function of STEAP3 was further investigated in an H 2 O 2 -induced AC16 cell model. Ferroptosis-related changes were assessed by measuring reactive oxygen species (ROS), malondialdehyde (MDA), glutathione peroxidase (GSH-Px), and ferrous ion (Fe 2+ ) levels. Ferroptosis, autophagy, and necroptosis were strongly correlated with aging in HF. Eighteen differentially expressed aging-related PCD genes were identified. The LASSO model showed the best diagnostic performance. Significant differences in the immune microenvironment were observed between the aging-PCD index-high and index-low groups. A regulatory network of 15 key genes and 19 transcription factors was constructed. The qRT-PCR results validated the bioinformatics analysis. Functional experiments further suggested that STEAP3 may participate in ferroptosis-related injury in cardiomyocytes, potentially through glutathione metabolism (GPX4/SLC7A11 axis) and iron homeostasis. We identified aging-related PCD signatures in HF that may provide candidate biomarkers for further clinical validation.

Kein medizinischer Rat. Die dargestellten Studien dienen der wissenschaftlichen Information und ersetzen keine ärztliche Beratung. Bei gesundheitlichen Fragen wende dich an eine approbierte Ärztin oder einen Arzt.

Quelle: PubMed Central / National Library of Medicine (NLM). Apollion steht in keiner Verbindung mit NLM und wird von NLM nicht empfohlen. Evidenzgrade bewerten die methodische Studienqualität — nicht die inhaltliche Richtigkeit.

Lizenz: CC BY — Inhalte werden ausschließlich aus Open-Access-Quellen mit kommerziell nutzbaren Lizenzen (CC0, CC BY, CC BY-SA) indexiert.